Santa Cruz Biotechnology delivers a wide array of KIF26A monoclonal antibodies for research applications. KIF26A monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIF26A, a member of the kinesin superfamily, plays a crucial role in intracellular transport and is involved in the regulation of neuronal development and function. KIF26A influences various cellular processes, including cell division and signaling pathways, making it a significant target for understanding neurodevelopmental disorders and other related conditions. Studying KIF26A expression and localization provides valuable information about cellular transport mechanisms and neuronal development. KIF26A research contributes to understanding both normal cellular functions and disease states. Investigating KIF26A activity helps reveal its role in maintaining cellular homeostasis and proper neuronal function. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of KIF26A's role in health and disease.